{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:05:25Z","timestamp":1769691925044,"version":"3.49.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["19-15-00245"],"award-info":[{"award-number":["19-15-00245"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.cbi.2020.109243","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T11:14:08Z","timestamp":1598526848000},"page":"109243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Upregulation of Akt\/Raptor signaling is associated with rapamycin resistance of breast cancer cells"],"prefix":"10.1016","volume":"330","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1490-6781","authenticated-orcid":false,"given":"Yuri","family":"Shchegolev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1264-7405","authenticated-orcid":false,"given":"Danila","family":"Sorokin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2974-9555","authenticated-orcid":false,"given":"Alexander","family":"Scherbakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5278-8037","authenticated-orcid":false,"given":"Alexey","family":"Shunaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6015-6619","authenticated-orcid":false,"given":"Olga","family":"Andreeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1299-9080","authenticated-orcid":false,"given":"Ekaterina","family":"Mikhaevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Gudkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Bure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5112-3372","authenticated-orcid":false,"given":"Lev","family":"Berstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Nemtsova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5902-7633","authenticated-orcid":false,"given":"Mikhail","family":"Krasil'nikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2020.109243_bib1","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.4161\/cbt.22859","article-title":"Rapalogs in cancer prevention: anti-aging or anticancer?","volume":"13","author":"Blagosklonny","year":"2012","journal-title":"Canc. Biol. Ther."},{"key":"10.1016\/j.cbi.2020.109243_bib2","doi-asserted-by":"crossref","DOI":"10.4161\/onci.26961","article-title":"Immunosuppressants in cancer prevention and therapy","volume":"2","author":"Blagosklonny","year":"2013","journal-title":"OncoImmunology"},{"key":"10.1016\/j.cbi.2020.109243_bib3","series-title":"mTOR: A Cellular Regulator Interface in Health and Disease","author":"Boutouja","year":"2019"},{"key":"10.1016\/j.cbi.2020.109243_bib4","first-page":"383","article-title":"mTOR function and therapeutic targeting in breast cancer","volume":"7","author":"Hare","year":"2017","journal-title":"Am. J. Canc. Res."},{"key":"10.1016\/j.cbi.2020.109243_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/1061186X.2016.1236112","article-title":"Recent advances in targeting mTOR signaling pathway using small molecule inhibitors","volume":"25","author":"Roohi","year":"2017","journal-title":"J. Drug Target."},{"key":"10.1016\/j.cbi.2020.109243_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2020.109243_bib7","doi-asserted-by":"crossref","first-page":"15619","DOI":"10.1074\/jbc.M800723200","article-title":"Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation","volume":"283","author":"Wang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2020.109243_bib8","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1126\/science.1187532","article-title":"mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs","volume":"328","author":"Dowling","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cbi.2020.109243_bib9","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.molcel.2010.05.017","article-title":"Structure of the human mTOR complex I and its implications for rapamycin inhibition","volume":"38","author":"Yip","year":"2010","journal-title":"Mol. Cell."},{"key":"10.1016\/j.cbi.2020.109243_bib10","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1002\/cncr.30286","article-title":"A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study)","volume":"122","author":"Makker","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.cbi.2020.109243_bib11","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1007\/s11033-020-05327-4","article-title":"The synergistic anti-proliferative effect of the combination of diosmin and BEZ-235 (dactolisib) on the HCT-116 colorectal cancer cell line occurs through inhibition of the PI3K\/Akt\/mTOR\/NF-\u03baB axis","volume":"47","author":"Helmy","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.cbi.2020.109243_bib12","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.4161\/cc.27982","article-title":"Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile","volume":"13","author":"Oliveras-Ferraros","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cbi.2020.109243_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/iub.1481","article-title":"The phenomenon of acquired resistance to metformin in breast cancer cells: the interaction of growth pathways and estrogen receptor signaling","volume":"68","author":"Scherbakov","year":"2016","journal-title":"IUBMB Life"},{"key":"10.1016\/j.cbi.2020.109243_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098207","article-title":"Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells","volume":"9","author":"Queiroz","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.cbi.2020.109243_bib15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/bab.1657","article-title":"Gemcitabine induces apoptosis and autophagy via the AMPK\/mTOR signaling pathway in pancreatic cancer cells","volume":"65","author":"Zhu","year":"2018","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.cbi.2020.109243_bib16","doi-asserted-by":"crossref","first-page":"13962","DOI":"10.18632\/oncotarget.3920","article-title":"AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1\/4E-BP1 axis","volume":"6","author":"Mi","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2020.109243_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071527","article-title":"Role played by signalling pathways in overcoming BRAF inhibitor resistance in melanoma","volume":"18","author":"Chan","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2020.109243_bib18","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1172\/JCI37539","article-title":"Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus","volume":"120","author":"Di Nicolantonio","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cbi.2020.109243_bib19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00280-018-3543-6","article-title":"Phosphorylation of AKT and ERK1\/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro","volume":"81","author":"Citi","year":"2018","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.cbi.2020.109243_bib20","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.bbagrm.2018.08.005","article-title":"MiR-19b non-canonical binding is directed by HuR and confers chemosensitivity through regulation of P-glycoprotein in breast cancer","volume":"1861","author":"Thorne","year":"2018","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"10.1016\/j.cbi.2020.109243_bib21","first-page":"2518","article-title":"MiR-26b regulates 5-FU-resistance in human colorectal cancer via down-regulation of Pgp","volume":"8","author":"Wang","year":"2018","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.cbi.2020.109243_bib22","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3389\/fnins.2018.00602","article-title":"MicroRNA-298 reverses multidrug resistance to antiepileptic drugs by suppressing MDR1\/P-gp expression in vitro","volume":"12","author":"Xie","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cbi.2020.109243_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.canlet.2017.08.027","article-title":"The miR-491-3p\/Sp3\/ABCB1 axis attenuates multidrug resistance of hepatocellular carcinoma","volume":"408","author":"Zhao","year":"2017","journal-title":"Canc. Lett."},{"key":"10.1016\/j.cbi.2020.109243_bib24","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/pros.23358","article-title":"MicroRNA-181a promotes docetaxel resistance in prostate cancer cells","volume":"77","author":"Armstrong","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.cbi.2020.109243_bib25","first-page":"1631","article-title":"miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN\/PI3K\/AKT pathway","volume":"39","author":"Liu","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cbi.2020.109243_bib26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/cam4.409","article-title":"Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells","volume":"4","author":"Weiner-Gorzel","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.cbi.2020.109243_bib27","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1096\/fj.201800618RRR","article-title":"Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway","volume":"33","author":"Zhou","year":"2019","journal-title":"Faseb. J: Offic. Pub. Federat. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.cbi.2020.109243_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121567","article-title":"Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells","volume":"10","author":"Bianchi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2020.109243_bib29","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1093\/cercor\/bhx201","article-title":"miR-181a participates in contextual fear memory formation via activating mTOR signaling pathway","volume":"28","author":"Xu","year":"2018","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.cbi.2020.109243_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1476-4598-13-229","article-title":"microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity","volume":"13","author":"Martin","year":"2014","journal-title":"Mol. Canc."},{"key":"10.1016\/j.cbi.2020.109243_bib31","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1158\/0008-5472.CAN-09-3970","article-title":"Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors","volume":"70","author":"Doghman","year":"2010","journal-title":"Canc. Res."},{"key":"10.1016\/j.cbi.2020.109243_bib32","first-page":"747","article-title":"The tetrazolium dye assay for rapid in vitro assessment of cytotoxicity","volume":"39","author":"Iselt","year":"1989","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.cbi.2020.109243_bib33","doi-asserted-by":"crossref","first-page":"42863","DOI":"10.1039\/C6RA06881B","article-title":"Access to steroidal pyridazines via modified thiohydrazides","volume":"6","author":"Volkova","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.cbi.2020.109243_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00979","article-title":"Steroidal pyrimidines and dihydrotriazines as novel classes of anticancer agents against hormone-dependent breast cancer cells","volume":"8","author":"Scherbakov","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2020.109243_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23040829","article-title":"Exosome-mediated transfer of cancer cell resistance to antiestrogen drugs","volume":"23","author":"Semina","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2020.109243_bib36","series-title":"Standard Guide for Measurement of Particle Size Distribution of Nanomaterials in Suspension by Nanoparticle Tracking Analysis (NTA)","year":"2012"},{"key":"10.1016\/j.cbi.2020.109243_bib37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cbi.2020.109243_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4161\/spmg.1.2.16606","article-title":"Enhanced chemiluminescence (ECL) for routine immunoblotting: an inexpensive alternative to commercially available kits","volume":"1","author":"Mruk","year":"2011","journal-title":"Spermatogenesis"},{"key":"10.1016\/j.cbi.2020.109243_bib39","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.phrs.2017.09.014","article-title":"Targeting activator protein 1 signaling pathway by bioactive natural agents: possible therapeutic strategy for cancer prevention and intervention","volume":"128","author":"Tewari","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2020.109243_bib40","series-title":"Anticancer mechanisms of metformin: a review of the current evidence","first-page":"117717","author":"Zhao","year":"2020"},{"key":"10.1016\/j.cbi.2020.109243_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jrr\/rrz102","article-title":"Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, induces accumulation of DNA double-strand breaks","volume":"61","author":"Ihara","year":"2020","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.cbi.2020.109243_bib42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ebiom.2016.08.016","article-title":"Prognostic value of a BCSC-associated MicroRNA signature in hormone receptor-positive HER2-negative breast cancer","volume":"11","author":"Gong","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cbi.2020.109243_bib43","first-page":"2004","article-title":"MiR-181a upregulation is associated with epithelial-to-mesenchymal transition (EMT) and multidrug resistance (MDR) of ovarian cancer cells","volume":"20","author":"Li","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2020.109243_bib44","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1158\/0008-5472.CAN-05-0917","article-title":"Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition","volume":"65","author":"Sun","year":"2005","journal-title":"Canc. Res."},{"key":"10.1016\/j.cbi.2020.109243_bib45","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.cub.2004.08.026","article-title":"Inappropriate activation of the TSC\/Rheb\/mTOR\/S6K cassette induces IRS1\/2 depletion, insulin resistance, and cell survival deficiencies","volume":"14","author":"Shah","year":"2004","journal-title":"Curr. Biol. : CB"},{"key":"10.1016\/j.cbi.2020.109243_bib46","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1083\/jcb.200403069","article-title":"The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins","volume":"166","author":"Harrington","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cbi.2020.109243_bib47","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt","volume":"66","author":"O'Reilly","year":"2006","journal-title":"Canc. Res."},{"key":"10.1016\/j.cbi.2020.109243_bib48","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1200\/JCO.2007.14.5482","article-title":"Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors","volume":"26","author":"Tabernero","year":"2008","journal-title":"J. Clin. Oncol. : Offic. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.cbi.2020.109243_bib49","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1158\/1535-7163.MCT-14-0330","article-title":"Suppression of feedback loops mediated by PI3K\/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance","volume":"13","author":"Rozengurt","year":"2014","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.cbi.2020.109243_bib50","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1038\/s41467-018-07188-9","article-title":"The critical role of AMPK in driving Akt activation under stress, tumorigenesis and drug resistance","volume":"9","author":"Han","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2020.109243_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057289","article-title":"Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells","volume":"8","author":"Soares","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2020.109243_bib52","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.18632\/oncotarget.2964","article-title":"Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers","volume":"6","author":"Bihani","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2020.109243_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191890","article-title":"RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition","volume":"13","author":"Earwaker","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2020.109243_bib54","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.biocel.2014.06.007","article-title":"Wortmannin potentiates the combined effect of etoposide and cisplatin in human glioma cells","volume":"53","author":"Pastwa","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cbi.2020.109243_bib55","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/ijc.21927","article-title":"Inhibitors of the PI3-kinase\/Akt pathway induce mitotic catastrophe in non-small cell lung cancer cells","volume":"119","author":"Hemstrom","year":"2006","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.cbi.2020.109243_bib56","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2010.11.012","article-title":"Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling","volume":"301","author":"He","year":"2011","journal-title":"Canc. Lett."},{"key":"10.1016\/j.cbi.2020.109243_bib57","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/cas.12566","article-title":"Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type","volume":"106","author":"de Souza","year":"2015","journal-title":"Canc. Sci."},{"key":"10.1016\/j.cbi.2020.109243_bib58","article-title":"Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs","volume":"9","author":"Chen","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.cbi.2020.109243_bib59","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/cam4.409","article-title":"Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells","volume":"4","author":"Weiner-Gorzel","year":"2015","journal-title":"Cancer medicine"},{"key":"10.1016\/j.cbi.2020.109243_bib60","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.2147\/IJN.S131516","article-title":"Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner","volume":"12","author":"Qin","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.cbi.2020.109243_bib61","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ccell.2016.03.004","article-title":"Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA","volume":"29","author":"Qu","year":"2016","journal-title":"Canc. Cell"},{"key":"10.1016\/j.cbi.2020.109243_bib62","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2119\/molmed.2010.00225","article-title":"let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor alpha signaling in breast cancer","volume":"17","author":"Zhao","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.cbi.2020.109243_bib63","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.22989","article-title":"Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells","volume":"50","author":"Ji","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2020.109243_bib64","doi-asserted-by":"crossref","first-page":"D239","DOI":"10.1093\/nar\/gkx1141","article-title":"DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions","volume":"46","author":"Karagkouni","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cbi.2020.109243_bib65","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/1471-2105-8-423","article-title":"PubMed related articles: a probabilistic topic-based model for content similarity","volume":"8","author":"Lin","year":"2007","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.cbi.2020.109243_bib66","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nmeth.1608","article-title":"A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins","volume":"8","author":"Kishore","year":"2011","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cbi.2020.109243_bib67","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1101\/gad.215939.113","article-title":"Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates","volume":"27","author":"Karginov","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.cbi.2020.109243_bib68","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cell.2012.11.045","article-title":"Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits","volume":"152","author":"Xue","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2020.109243_bib69","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cmet.2013.11.016","article-title":"Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets","volume":"19","author":"Kameswaran","year":"2014","journal-title":"Cell Metabol."},{"key":"10.1016\/j.cbi.2020.109243_bib70","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.3892\/ijo.2015.2896","article-title":"miR-181c promotes proliferation via suppressing PTEN expression in inflammatory breast cancer","volume":"46","author":"Zhang","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cbi.2020.109243_bib71","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4103\/1673-5374.272612","article-title":"MicroRNA-181c provides neuroprotection in an intracerebral hemorrhage model","volume":"15","author":"Lu","year":"2020","journal-title":"Neural. Regenerat. Res."},{"key":"10.1016\/j.cbi.2020.109243_bib72","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00280-017-3435-1","article-title":"miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1","volume":"80","author":"Zhang","year":"2017","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.cbi.2020.109243_bib73","doi-asserted-by":"crossref","DOI":"10.1507\/endocrj.EJ18-0538","article-title":"MiR-181c affects estrogen-dependent endometrial carcinoma cell growth by targeting PTEN","author":"Zhuang","year":"2019","journal-title":"Endocr. J."},{"key":"10.1016\/j.cbi.2020.109243_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.29640","article-title":"The role of miR-34 in cancer drug resistance","author":"Naghizadeh","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cbi.2020.109243_bib75","doi-asserted-by":"crossref","first-page":"144453","DOI":"10.1016\/j.gene.2020.144453","article-title":"Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer","volume":"738","author":"Najjary","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.cbi.2020.109243_bib76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10555-017-9724-7","article-title":"miR-155 in cancer drug resistance and as target for miRNA-based therapeutics","volume":"37","author":"Bayraktar","year":"2018","journal-title":"Canc. Metastasis Rev."},{"key":"10.1016\/j.cbi.2020.109243_bib77","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jbior.2018.02.002","article-title":"Metformin influences drug sensitivity in pancreatic cancer cells","volume":"68","author":"Candido","year":"2018","journal-title":"Adv. Biol. Regulate."},{"key":"10.1016\/j.cbi.2020.109243_bib78","doi-asserted-by":"crossref","first-page":"9666","DOI":"10.1038\/s41598-019-46132-9","article-title":"MicroRNA signature refine response prediction in CML","volume":"9","author":"Alves","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2020.109243_bib79","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00432-017-2562-8","article-title":"MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment","volume":"144","author":"Xu","year":"2018","journal-title":"J. Canc. Res. Clin. Oncol."},{"key":"10.1016\/j.cbi.2020.109243_bib80","first-page":"17","article-title":"Exosome and exosomal microRNA: trafficking, sorting, and function","volume":"13","author":"Zhang","year":"2015","journal-title":"Dev. Reprod. Biol."},{"key":"10.1016\/j.cbi.2020.109243_bib81","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1038\/ncomms3980","article-title":"Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs","volume":"4","author":"Villarroya-Beltri","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2020.109243_bib82","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12033-013-9672-6","article-title":"A defined methodology for reliable quantification of Western blot data","volume":"55","author":"Taylor","year":"2013","journal-title":"Mol. Biotechnol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719315030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719315030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:02:43Z","timestamp":1757858563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279719315030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":82,"alternative-id":["S0009279719315030"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2020.109243","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upregulation of Akt\/Raptor signaling is associated with rapamycin resistance of breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2020.109243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109243"}}